Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
13.76
-0.13 (-0.94%)
May 20, 2026, 12:34 PM CST

SHE:002275 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,1042,0462,1922,1681,9541,739
Other Revenue
--1.763.665.272.71
2,1042,0462,1942,1721,9601,741
Revenue Growth (YoY)
-3.38%-6.76%1.03%10.81%12.55%11.15%
Cost of Revenue
479.79490.41610.47602.57574.37457.04
Gross Profit
1,6241,5551,5841,5691,3851,284
Selling, General & Admin
815.45817.78888.26920.66812.68722.13
Research & Development
174.93160.04173.29158.06217.04201.6
Other Operating Expenses
12.599.3632.2829.8936.0932.8
Operating Expenses
1,037987.181,1031,1091,070957.81
Operating Income
587.41568.15480.47460.41315.65326.37
Interest Expense
---13.84-16.36-20.24-18.21
Interest & Investment Income
7.135.2534.433.1740.6439.8
Currency Exchange Gain (Loss)
--0.19-0.08-3.590.57
Other Non Operating Income (Expenses)
-26.02-26.17-0.250.05-0.58-1.23
EBT Excluding Unusual Items
568.52547.22500.97477.2331.89347.31
Gain (Loss) on Sale of Investments
8.767.714.651.190.161.77
Gain (Loss) on Sale of Assets
0.140.1583.361.6731.2615.5
Asset Writedown
-18.16-18.16-0.86-0.17-1.02-8.12
Other Unusual Items
--55.8238.3983.8972.61
Pretax Income
559.25536.93643.93518.28446.18429.06
Income Tax Expense
106.58103.79122.496.99116.6585.34
Net Income
452.67433.13521.53421.3329.53343.72
Net Income to Common
452.67433.13521.53421.3329.53343.72
Net Income Growth
-13.99%-16.95%23.79%27.85%-4.13%24.08%
Shares Outstanding (Basic)
588585586585588573
Shares Outstanding (Diluted)
588585586585588573
Shares Change (YoY)
0.56%-0.11%0.15%-0.56%2.72%-0.74%
EPS (Basic)
0.770.740.890.720.560.60
EPS (Diluted)
0.770.740.890.720.560.60
EPS Growth
-14.48%-16.85%23.61%28.57%-6.67%25.00%
Free Cash Flow
584.84621.18506.16472.85466.4266.15
Free Cash Flow Per Share
0.991.060.860.810.790.47
Dividend Per Share
--0.6000.6000.8000.900
Dividend Growth
----25.00%-11.11%125.00%
Gross Margin
77.20%76.03%72.17%72.25%70.69%73.75%
Operating Margin
27.91%27.77%21.90%21.20%16.11%18.74%
Profit Margin
21.51%21.17%23.77%19.40%16.81%19.74%
Free Cash Flow Margin
27.79%30.36%23.07%21.77%23.80%15.29%
EBITDA
673.13654.91571.42575.53412.21412.97
EBITDA Margin
31.99%32.01%26.05%26.50%21.03%23.72%
D&A For EBITDA
85.7186.7690.95115.1296.5586.6
EBIT
587.41568.15480.47460.41315.65326.37
EBIT Margin
27.91%27.77%21.90%21.20%16.11%18.74%
Effective Tax Rate
19.06%19.33%19.01%18.71%26.15%19.89%
Revenue as Reported
58.55-2,1942,1721,9601,741
Advertising Expenses
--530.36514.72361.86378.93
Source: S&P Global Market Intelligence. Standard template. Financial Sources.